Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression

Clinical trial NCT05154383 · COMPLETED

Trial details

NCT number: NCT05154383
Sponsor: Centre Hospitalier Annecy Genevois
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccine Reaction

Start date: 2021-11-15
Primary completion: 2022-07-21
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.